ArticleFrontiers in pharmacology2016
Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center Study.
Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Relationship between NLR and penile squamous cell carcinoma: a systematic review and meta-analysis.BMC urology · 2024Pooled it
- Trial
- A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.The Journal of international medical research · 2019Trial
- Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review.International journal of molecular sciences · 2025Review
- The Utility of Salvage Radiotherapy for an Inoperable Inguinal Recurrence of Squamous Cell Carcinoma of the Penis.Cureus · 2023Article
- Clinical Profile and Predictors of Survival in Carcinoma Penis Patients.Current oncology (Toronto, Ont.) · 2023Article
- Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments.Research and reports in urology · 2023Review
- Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset Analysis.Frontiers in oncology · 2022Article
- An update on treatment of penile cancer.Therapeutic advances in medical oncology · 2022Review
- Immune checkpoint inhibitors in penile cancer.Future science OA · 2021Article
- Penile cancer: potential target for immunotherapy?World journal of urology · 2021Review
- Experimental Models for Studying HPV-Positive and HPV-Negative Penile Cancer: New Tools for An Old Disease.Cancers · 2021Review
- Penile cancer: a Brazilian consensus statement for low- and middle-income countries.Journal of cancer research and clinical oncology · 2020Review
- Article
- Immunotherapy for advanced penile cancer - rationale and potential.Nature reviews. Urology · 2018Article
- [Molecular characterization of penile cancer : Literature review of new prognostic markers and potential therapeutic targets].Der Urologe. Ausg. A · 2018Review
- Penile cancer: Targeted therapy in penile cancer: a new treatment paradigm.Nature reviews. Urology · 2018Article
- Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.International journal of molecular sciences · 2017Review
- Immunotherapy for penile cancer.Future science OA · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 7 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.